Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
19361
-
19362
<b>Ensemble learning model identifies </b><b>adaptation classification and turning points</b><b> of river microbial communities in response to heatwaves</b>
Published 2024“…If emissions of particulate matter with sizes not more than 2.5 μm (PM2.5, an indicator of human activities) increase by 2-fold, the number of global rivers associated with the fast stress adaptation type will decrease by ~13.7% after heatwave disturbances. …”
-
19363
Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation
Published 2016“…While MYC was required for MCT1 induction, MCPyV-induced MCT1 levels decreased following knockdown of the NF-κB subunit RelA, supporting a synergistic activity between MCPyV and MYC in regulating MCT1 levels. …”
-
19364
-
19365
-
19366
-
19367
-
19368
A Family of Binuclear Dysprosium(III) Radical Compounds with Magnetic Relaxation in ON and OFF States
Published 2012“…The adduct ([Dy(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub>[Dy<sub>0.5</sub>(hfac)<sub>1.5</sub>(H<sub>2</sub>O)]<sub>2</sub>) (<b>3</b>) consists of two items, the dimer [Dy(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub> and the monomer [Dy(hfac)<sub>3</sub>(H<sub>2</sub>O)<sub>2</sub>], where the symmetry of Dy<sup>III</sup> ion in Dy<sub>2</sub>O<sub>2</sub> decreases to <i>D</i><sub>2<i>d</i></sub>, showing slow relaxation of the magnetization at lower temperature. …”
-
19369
Physiological Markers of Arousal Change with Psychological Treatment for Insomnia: A Preliminary Investigation
Published 2015“…</p><p>Results</p><p>Eight (73%) patients out of 11 consented completed therapy and showed a decrease in insomnia severity pre-to-post treatment (mean (SD): 18.1 (2.8) versus 8.4 (4.8); <i>p</i> = .001). …”
-
19370
-
19371
-
19372
-
19373
-
19374
-
19375
-
19376
The data of meta-analysis.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
19377
Quality assessment for risk of bias for studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
19378
Effect of tirzepatide vs placebo on body weight.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
19379
The results of safety in meta-analysis.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
19380
Graphs of risk of bias for studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”